J 2021

Consistent B Cell Receptor Immunoglobulin Features Between Siblings in Familial Chronic Lymphocytic Leukemia

KOLIJN, P.M., A.F. MUGGEN, V. LJUNGSTROM, A. AGATHANGELIDIS, I.L.M. WOLVERS-TETTERO et. al.

Basic information

Original name

Consistent B Cell Receptor Immunoglobulin Features Between Siblings in Familial Chronic Lymphocytic Leukemia

Authors

KOLIJN, P.M., A.F. MUGGEN, V. LJUNGSTROM, A. AGATHANGELIDIS, I.L.M. WOLVERS-TETTERO, H.B. BEVERLOO, Karol PÁL (703 Slovakia, belonging to the institution), P.J. HENGEVELD, N. DARZENTAS, R.W. HENDRIKS, J.J.M. VAN DONGEN, R. ROSENQUIST and A.W. LANGERAK

Edition

Frontiers in Oncology, Lausanne, Frontiers Media S.A. 2021, 2234-943X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 5.738

RIV identification code

RIV/00216224:14740/21:00124302

Organization unit

Central European Institute of Technology

UT WoS

000698022400001

Keywords in English

CLL (Chronic Lymphocytic Leukemia); Familial CLL; BCR stereotypy; IGLV3-21 R110; CLL development

Tags

Tags

International impact, Reviewed
Změněno: 26/2/2022 14:05, Mgr. Pavla Foltynová, Ph.D.

Abstract

V originále

Key processes in the onset and evolution of chronic lymphocytic leukemia (CLL) are thought to include chronic (antigenic) activation of mature B cells through the B cell receptor (BcR), signals from the microenvironment, and acquisition of genetic alterations. Here we describe three families in which two or more siblings were affected by CLL. We investigated whether there are immunogenetic similarities in the leukemia-specific immunoglobulin heavy (IGH) and light (IGL/IGK) chain gene rearrangements of the siblings in each family. Furthermore, we performed array analysis to study if similarities in CLL-associated chromosomal aberrations are present within each family and screened for somatic mutations using paired tumor/normal whole-genome sequencing (WGS). In two families a consistent IGHV gene mutational status (one IGHV-unmutated, one IGHV-mutated) was observed. Intriguingly, the third family with four affected siblings was characterized by usage of the lambda IGLV3-21 gene, with the hallmark R110 mutation of the recently described clinically aggressive IGLV3-21(R110) subset. In this family, the CLL-specific rearrangements in two siblings could be assigned to either stereotyped subset #2 or the immunogenetically related subset #169, both of which belong to the broader IGLV3-21(R110) subgroup. Consistent patterns of cytogenetic aberrations were encountered in all three families. Furthermore, the CLL clones carried somatic mutations previously associated with IGHV mutational status, cytogenetic aberrations and stereotyped subsets, respectively. From these findings, we conclude that similarities in immunogenetic characteristics in familial CLL, in combination with genetic aberrations acquired, point towards shared underlying mechanisms behind CLL development within each family.